Cefazolin for hysterectomy prophylaxis

D. L. Hemsell, E. R. Johnson, P. G. Hemsell, B. J. Nobles, M. C. Heard

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Efficacy data for single-dose cefazolin prophylaxis at hysterectomy are meager, and there are none evaluating the impact of route of administration on efficacy. For these reasons, 772 women undergoing elective abdominal or vaginal hysterectomy for benign diseases were given 1 g cefazolin either intramuscularly or intravenously in a randomized clinical trial. Preoperative diagnoses and clinical, surgical, and outcome variables were similar by route of administration for each surgical approach. Risk factors for infection after abdominal hysterectomy included younger age, lower post-operative hemoglobin concentration, and pelvic hematoma; women who developed infection after vaginal hysterectomy were heavier than thsoe who remained uninfected and were more likely to have a pelvic hematoma. The overall incidence of major operative site infection requiring parenteral antimicrobial therapy in evaluable women was 7.2%: 7.6% for 539 women undergoing abdominal hysterectomy and 6.3% for 207 women undergoing vaginal hysterectomy. Postoperative infection was unrelated to route of cefazolin administration.

Original languageEnglish (US)
Pages (from-to)603-606
Number of pages4
JournalObstetrics and Gynecology
Volume76
Issue number4
StatePublished - 1990

Fingerprint

Cefazolin
Hysterectomy
Vaginal Hysterectomy
Infection
Hematoma
Hemoglobins
Randomized Controlled Trials
Incidence

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Hemsell, D. L., Johnson, E. R., Hemsell, P. G., Nobles, B. J., & Heard, M. C. (1990). Cefazolin for hysterectomy prophylaxis. Obstetrics and Gynecology, 76(4), 603-606.

Cefazolin for hysterectomy prophylaxis. / Hemsell, D. L.; Johnson, E. R.; Hemsell, P. G.; Nobles, B. J.; Heard, M. C.

In: Obstetrics and Gynecology, Vol. 76, No. 4, 1990, p. 603-606.

Research output: Contribution to journalArticle

Hemsell, DL, Johnson, ER, Hemsell, PG, Nobles, BJ & Heard, MC 1990, 'Cefazolin for hysterectomy prophylaxis', Obstetrics and Gynecology, vol. 76, no. 4, pp. 603-606.
Hemsell DL, Johnson ER, Hemsell PG, Nobles BJ, Heard MC. Cefazolin for hysterectomy prophylaxis. Obstetrics and Gynecology. 1990;76(4):603-606.
Hemsell, D. L. ; Johnson, E. R. ; Hemsell, P. G. ; Nobles, B. J. ; Heard, M. C. / Cefazolin for hysterectomy prophylaxis. In: Obstetrics and Gynecology. 1990 ; Vol. 76, No. 4. pp. 603-606.
@article{05054bae5bee47f29d45f54a356b7420,
title = "Cefazolin for hysterectomy prophylaxis",
abstract = "Efficacy data for single-dose cefazolin prophylaxis at hysterectomy are meager, and there are none evaluating the impact of route of administration on efficacy. For these reasons, 772 women undergoing elective abdominal or vaginal hysterectomy for benign diseases were given 1 g cefazolin either intramuscularly or intravenously in a randomized clinical trial. Preoperative diagnoses and clinical, surgical, and outcome variables were similar by route of administration for each surgical approach. Risk factors for infection after abdominal hysterectomy included younger age, lower post-operative hemoglobin concentration, and pelvic hematoma; women who developed infection after vaginal hysterectomy were heavier than thsoe who remained uninfected and were more likely to have a pelvic hematoma. The overall incidence of major operative site infection requiring parenteral antimicrobial therapy in evaluable women was 7.2{\%}: 7.6{\%} for 539 women undergoing abdominal hysterectomy and 6.3{\%} for 207 women undergoing vaginal hysterectomy. Postoperative infection was unrelated to route of cefazolin administration.",
author = "Hemsell, {D. L.} and Johnson, {E. R.} and Hemsell, {P. G.} and Nobles, {B. J.} and Heard, {M. C.}",
year = "1990",
language = "English (US)",
volume = "76",
pages = "603--606",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cefazolin for hysterectomy prophylaxis

AU - Hemsell, D. L.

AU - Johnson, E. R.

AU - Hemsell, P. G.

AU - Nobles, B. J.

AU - Heard, M. C.

PY - 1990

Y1 - 1990

N2 - Efficacy data for single-dose cefazolin prophylaxis at hysterectomy are meager, and there are none evaluating the impact of route of administration on efficacy. For these reasons, 772 women undergoing elective abdominal or vaginal hysterectomy for benign diseases were given 1 g cefazolin either intramuscularly or intravenously in a randomized clinical trial. Preoperative diagnoses and clinical, surgical, and outcome variables were similar by route of administration for each surgical approach. Risk factors for infection after abdominal hysterectomy included younger age, lower post-operative hemoglobin concentration, and pelvic hematoma; women who developed infection after vaginal hysterectomy were heavier than thsoe who remained uninfected and were more likely to have a pelvic hematoma. The overall incidence of major operative site infection requiring parenteral antimicrobial therapy in evaluable women was 7.2%: 7.6% for 539 women undergoing abdominal hysterectomy and 6.3% for 207 women undergoing vaginal hysterectomy. Postoperative infection was unrelated to route of cefazolin administration.

AB - Efficacy data for single-dose cefazolin prophylaxis at hysterectomy are meager, and there are none evaluating the impact of route of administration on efficacy. For these reasons, 772 women undergoing elective abdominal or vaginal hysterectomy for benign diseases were given 1 g cefazolin either intramuscularly or intravenously in a randomized clinical trial. Preoperative diagnoses and clinical, surgical, and outcome variables were similar by route of administration for each surgical approach. Risk factors for infection after abdominal hysterectomy included younger age, lower post-operative hemoglobin concentration, and pelvic hematoma; women who developed infection after vaginal hysterectomy were heavier than thsoe who remained uninfected and were more likely to have a pelvic hematoma. The overall incidence of major operative site infection requiring parenteral antimicrobial therapy in evaluable women was 7.2%: 7.6% for 539 women undergoing abdominal hysterectomy and 6.3% for 207 women undergoing vaginal hysterectomy. Postoperative infection was unrelated to route of cefazolin administration.

UR - http://www.scopus.com/inward/record.url?scp=0025183067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025183067&partnerID=8YFLogxK

M3 - Article

C2 - 2216187

AN - SCOPUS:0025183067

VL - 76

SP - 603

EP - 606

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -